Here are 13 spine and neurosurgeons making the news this week:
Wilson Asfora, MD, filed a wrongful termination countersuit against the Sioux Falls-based Sanford Health, claiming he was a victim of vindictive colleagues.
Jeffrey Wang, MD, co-director of the USC Spine Center at Keck Medicine of USC in Los Angeles, spoke to Becker's Spine Review about stem cells and the future of regenerative medicine in spine.
Plano-based Texas Back Institute's Peter Derman, MD, completed the first procedure with the E3 MIS pedicle screw system.
Chiu Yuen To, DO, a neurosurgeon with Saint Francis Medical Partners in Memphis, performed one of the first procedures with the Corus system, a new cervical spinal fusion device.
Norwood, Ohio-based Mayfield Brain & Spine's Vincent DiNapoli, MD, PhD, was reportedly the first neurosurgeon in the country to treat newly diagnosed malignant brain tumors with GammaTile Therapy.
Kevin Pauza, MD, discussed biologics in spine and what treatments he anticipates making a breakthrough in the field.
Neurosurgeon Zachary Smith, MD, joined Oklahoma City-based OU Medicine.
Robert Froh, MD, of Surrey Comprehensive Orthopaedics in Canada, won $500,000 in the Feb. 21 Maxmillions lottery draw.
Axis Spine Center, co-owned by Roland Kent, MD, is moving from Post Falls to Coeur d'Alene, Idaho.
Andrew Hecht, MD, chief of spine surgery at New York City-based Mount Sinai Hospital, discussed key patient evaluation considerations for outpatient surgeries and future trends in spine care.
San Antonio-based SASpine partnered with Stanley Jones, MD, and established a new primary location in Houston.
Roger Härtl, MD, director of spinal surgery and neurotrauma at Weill Cornell Brain and Spine Center in New York City, spoke to Becker's Spine Review about trends in spinal biologics.
Michael Rohmiller, MD, of Cincinnati-based Beacon Orthopaedics and Sports Medicine, discussed strategies for combatting rising costs and earning better reimbursement rates from payers.